Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line

Hepatology

Volumn 30, Issue 5, 1999, Pages 1128-1133

  Park, Joongwon ^a,c   Tadlock, Laura ^b   Gores, Gregory J ^a   Patel, Tushar ^b,d  

^a MAYO CLINIC   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c Chung Ang University College of Medicine   (South Korea)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; AUTOCRINE EFFECT; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PARACRINE SIGNALING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL DIVISION; CHOLANGIOCARCINOMA; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; IMIDAZOLES; INTERLEUKIN-1; INTERLEUKIN-6; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032714310     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300522     Document Type: Article

References (28)

1. Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ. Cholangiocarcinoma: a review. Gastroenterologist 1997;5:306-315.
2. Roberts S, Ludwig J, LaRusso N. The pathobiology of biliary epithelia. Gastroenterology 1997;112:269-279.
3. Sehgal P. Interleukin-6: a regulator of plasma protein gene expression in hepatic and non-hepatic tissues. Mol Biol Med 1990;7:117-130.
4. Kanazawa A, Kinoshita H, Hirohashi K, Kubo S, Tsukamoto T, Hamba H, Shuto T. Concentrations of bile and serum endotoxin and serum cytokines after biliary drainage for acute cholangitis. Osaka City Med J 1997;43:15-27.
5. Rosen HR, Winkle PJ, Kendall BJ, Diehl DL. Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography. Dig Dis Sci 1997;42:1290-1294.
6. Goydos JS, Brumfield AM, Frezza E, Booth A, Lotze MT, Carty SE. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker. Ann Surg 1998;227:398404.
7. Okada K, Shimizu Y, Nambu S, Higuchi K, Watanabe A. Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line. J Gastroenterol Hepatol 1994;9:462-467.
8. Sugawara H, Yasoshima M, Kalayanagi K, Kono N, Watanabe Y, Harada K, Nakanuma Y. Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma. Histopathology 1998;33:145-153.
9. Simpson R, Hammacher A, Smith D, Matthews J, Ward L. Interleukin-6: structure-function relationships. Protein Sci 1997;6:929-955.
10. Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990;8:253-278.
11. Taga T, Kishimoto T. gp130 and the Interleukin-6 family of cytokines. Annu Rev Immunol 1997;15:797-819.
12. Hirano T. Interleukin-6 and its receptor: ten years later. Int Rev Immunol 1998;16:249-284.
13. Park J, Gores, GJ, Patel T. Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6 mediated activation of p44/p42 mitogen activated protein kinase. HEPATOLOGY 1999;29:1037-1043.
14. Brunet A, Pouyssegur J. Mammalian MAP kinase modules: how to transduce specific signals. Essays Biochem 1997;32:1-16.
15. Harnois DM, Que FG, Celli A, LaRusso NF, Gores GJ. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. HEPATOLOGY 1997;26:884-890.
16. Grubman S, Perrone R, Lee D, Murray S, Rogers L, Wolkoff L, Mulberg A, et al. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am J Physiol 1994;266(Gastrointest Liver Physiol 29):G1060-G1070.
17. Lust J, Jelinek D, Donovan K, Frederick L, Huntley B, Maihle N. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R). Curr Top Microbiol Immunol 1995;194:199-206.
18. Adjei P, Kaufmann S, Leung W-Y, Mao F, Gores G. Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease p32. J Clin Invest 1996;98:2588-2596.
19. Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. HEPATOLOGY 1994;20:376-382.
20. Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994;94:2183-2192.
21. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270:27489-27494.
22. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 1995;92:7686-7689.
23. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995;364: 229-233.
24. Su GH, Hilgers W, Shekher MC, Tang DJ, Yeo CJ, Hruban RH, Kern SE. Allerations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res 1998;58: 2339-2342.
25. Zhengui Xia, Dickens, M, Raingeaud J, Davis, RJ, Greenberg, ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-1331.
26. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44 MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 1996;271:20608-20616.
27. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, el al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997;275: 90-94.
28. Kummer JL, Rao PK, Heidenreich KA. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 1997;272:20490-20494.